Breast Cancers With Discordant Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization-Positive (Group 1) and Immunohistochemistry-Negative (0/11) Results Following American Society of Clinical Oncology/College of American Pathologists Guideline. - Wilcock, Diane; Jedrzkiewicz, Jolanta; Cleary, Allison S.; Beech, Cameron; Gulbahce, H. Evin (Archives of Pathology & Laboratory Medicine, 2026)